Company: LDDD
Filing Date: 2025-09-26
Form Type: 10-K
Source: 0001213900-25-091988
Chunk: 116

Company: Longduoduo Co Ltd
Filing Date: 2025-09-26
Form: 10-K
Item: Item 1A
Chunk 116
---
 of our financial statements. It remains unclear what the SEC’s implementation process related to the June 2021 interim
final amendments will entail or what further actions the SEC or the PCAOB will take to address these issues and what impact those actions
will have on U.S. companies that have significant operations in the PRC and have securities listed on a U.S. stock exchange (including
a national securities exchange or over-the-counter stock market). In addition, the June 2021 interim final amendments and any additional
actions, proceedings, or new rules resulting from these efforts to increase U.S. regulatory access to audit information could create
some uncertainty for investors, the market price of our common stock could be adversely affected, and we could be delisted if we and
our auditor are unable to meet the PCAOB inspection requirement or being required to engage a new audit firm, which would require significant
expense and management time.   

Restrictions
contained in Chinese law on the ability of overseas securities regulators to collect information in China may deny investors in our Company
the benefits of U.S. securities regulation.

China
has often restricted U.S. regulators’ access to information and limited regulators’ ability to investigate or pursue remedies
with respect to China-based issuers, generally citing to state secrecy and national security laws, blocking statutes, or other laws or
regulations. In addition, according to Article 177 of the PRC Securities Law, which became effective in March 2020, no overseas securities
regulator can directly conduct investigations or evidence collection activities within the PRC and no entity or individual in China may
provide documents and information relating to securities business activities to overseas regulators without Chinese government approval.
The SEC, U.S. Department of Justice, and other U.S. authorities face substantial challenges in bringing and enforcing actions against
China-based issuers and their officers and directors. As a result, investors in our Company may not benefit from a regulatory environment
that fosters effective enforcement of U.S. federal securities laws.

According
to Article 177, there are uncertainties as to the procedures and requisite timing for the U.S. securities regulatory agencies
to conduct investigations and collect evidence within the territory of the PRC. If the U.S. securities regulatory
agencies are unable to conduct such investigations, there exists a risk that they may determine to suspend or de-register our registration
with the SEC and may also delist our securities from OTC Markets or other applicable